Top FDA official cancels staff to approve failed gene therapy trial
Larger / Dr. Peter Marks, Director of the Center for Biological Evaluation and Research within the Food and Drug Administration on March 18, 2021 in Washington, DC. The Food and Drug Administration (FDA) on Thursday announced expanded approval for a gene therapy to treat Duchenne muscular dystrophy (DMD) — despite the fact that it failed … Read more